New in MMWR: Bivalent Booster Effectiveness; Paxlovid and Decreased Hospitalizations

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

MMWR banner

November 22, 2022

EARLY RELEASE

This figure is a photo of a COVID-19 vaccine drive-thru sign with text that reads, “An updated (bivalent) COVID-19 booster provides additional protection against symptomatic COVID-19 illness. COVID-19 spread has increased during the last two winters; stay up to date with COVID-19 vaccination”


Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022





This figure is a photo of an ambulance next to the title, “Real-world data shows early treatment for COVID-19 helps prevent hospitalization.” On the left column is “Adults prescribed Paxlovid for mild-to-moderate COVID-19 were 51% less likely to be hospitalized than those who weren’t.” On the right column states “If you have COVID-19 symptoms: TEST, Use a self-test, locate a test site or find a Test to Treat location; TALK, If you test positive talk to a health care professional about treatment; TREAT, Start treatment within 5 days.”


Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022





This figure is an image of a microphone on a dark background with sound waves and the text “MMWR Weekly Briefing,” representing the MMWR podcast.

MMWR Weekly Briefing Podcast: Week of November 7

 

The latest MMWR Weekly Briefing is live. This episode covers four reports, including reports highlighting tobacco product use among middle school and high school students, COVID-19–associated hospitalizations among U.S. infants and more. Listen and subscribe on: Apple Podcasts, Stitcher, Spotify, and Google Play.


CDC Facebook CDC Twitter CDC Streaming Health CDC Instagram

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 

[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux